Wave Life Sciences to Present at RBC Capital Markets Global Healthcare Virtual Conference
May 10 2021 - 3:05PM
Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage
genetic medicines company committed to delivering life-changing
treatments for people battling devastating diseases, announced
today that Paul Bolno, MD, MBA, President and Chief Executive
Officer is scheduled to give a presentation at the RBC Capital
Markets Global Healthcare Virtual Conference on Wednesday, May
19, 2021 at 4:15 p.m. ET.
A live webcast of the presentation will be available on the
investor relations page of the Wave Life
Sciences corporate website
at http://ir.wavelifesciences.com. A replay of the
presentation will be archived and available at that site for 90
days following the event.
About Wave Life Sciences Wave Life
Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines
company committed to delivering life-changing treatments for people
battling devastating diseases. Wave aspires to develop
best-in-class medicines across multiple therapeutic modalities
using PRISM, the company’s proprietary discovery and drug
development platform that enables the precise design, optimization
and production of stereopure oligonucleotides. Driven by a resolute
sense of urgency, the Wave team is targeting a broad range of
genetically defined diseases so that patients and families may
realize a brighter future. To find out more, please
visit www.wavelifesciences.com and follow Wave on Twitter
@WaveLifeSci.
Investor Contact:Kate
Rausch617-949-4827krausch@wavelifesci.com
Media Contact:Alicia
Suter617-949-4817asuter@wavelifesci.com
Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
From Apr 2024 to May 2024
Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
From May 2023 to May 2024